Keynote-524. The immunomodulatory effect of lenvatinib (a multikinase inhibitor) on tumor microenvironments may contribute to antitumor activity when combined with. We would like to show you a description here but the site won’t allow us.
Lenvatinib (dosing for patients who weigh ≥60 kg was 12 mg/day; The immunomodulatory effect of lenvatinib (a multikinase inhibitor) on tumor microenvironments may contribute to antitumor activity when combined with.